Specific clinical and immune features of CD68 in glioma via 1,024 samples

Abstract

Our results demonstrated that CD68 acted as an immune suppressor and contributed to glioma progression in the tumor microenvironment. These findings may expand our understanding of CD68-specific clinical and immune features in glioma.